In today’s recent session, 1.44 million shares of the Opko Health Inc (NASDAQ:OPK) have been traded, and its beta is 1.19. Most recently the company’s share price was $1.34, and it changed around -$0.02 or -1.15% from the last close, which brings the market valuation of the company to $1.07B. OPK at last check was trading at a discount to its 52-week high of $2.04, offering almost -52.24% off that amount. The share price’s 52-week low was $1.21, which indicates that the recent value has risen by an impressive 9.7% since then. We note from Opko Health Inc’s average daily trading volume that its 10-day average is 2.78 million shares, with the 3-month average coming to 3.32 million.
Opko Health Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended OPK as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Opko Health Inc is expected to report earnings per share of -0.1 for the current quarter.
Opko Health Inc (NASDAQ:OPK) trade information
Instantly OPK has been showing red trend so far today with a performance of -1.15% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.3800 on recent trading dayincreased the stock’s daily price by 2.9%. The company’s shares are currently up 6.70% year-to-date, but still up 1.08% over the last five days. On the other hand, Opko Health Inc (NASDAQ:OPK) is -1.15% down in the 30-day period. We can see from the shorts that 31.0 million shares have been sold at a short interest cover period of 10.97 day(s).
The consensus price target as assigned by Wall Street analysts is $3.5, which translates to bulls needing to increase their stock price by 61.71% from its current value. Analyst projections state that OPK is forecast to be at a low of $3 and a high of $4.
Opko Health Inc (OPK) estimates and forecasts
The year-over-year growth rate is expected to be -8.53%, down from the previous year.
Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 165.74M in revenue for the current quarter. 7 analysts expect Opko Health Inc to make 167.83M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 182.2M and 173.6M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -9.03%. Forecasts for the next quarter put sales growth at -3.32%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 32.04%. Opko Health Inc earnings are expected to increase by -335.42% in 2025, but the outlook is negative -4.00% per year for the next five years.
OPK Dividends
Opko Health Inc’s next quarterly earnings report is expected to be released on 2025-Apr-30.
Opko Health Inc (NASDAQ:OPK)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 46.81% of Opko Health Inc shares, and 31.11% of them are in the hands of institutional investors. The stock currently has a share float of 58.49%. Opko Health Inc stock is held by 312.0 institutions, with RUBRIC CAPITAL MANAGEMENT LP being the largest institutional investor. By 2024-06-30, it held 6.3714% of the shares, which is about 44.42 million shares worth $55.53 million.
BLACKROCK INC., with 4.1946% or 29.25 million shares worth $36.56 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Mar 31, 2025 . The former held 8.78 shares worth $11.93 million, making up 1.11% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 8.19 shares worth around $11.12 million, which represents about 1.03% of the total shares outstanding.
